MBF Therapeutics Inc. (MBFT) is a veterinary oncology company dedicated to advancing the standard of cancer care for companion animals. We are working with cancer researchers and veterinary clinicians to develop new, innovative and humane therapies for the treatment of dogs and cats with cancer. We are taking advantage of many significant advances that have been made in human cancer treatment to adapt therapies proven safe and effective in human clinical studies for use in companion animals.
Our products are not yet commercially available. We are planning and conducting clinical evaluations of our products in collaboration with professional veterinary organizations throughout the United States.
We are planning and conducting clinical evaluations of our products
MBFT-101 is currently being evaluated as a treatment for cats with nonresectable oral squamous cell carcinoma. This clinical study, being conducted at the University of Pennsylvania, is now recruiting feline patients.
For more information about this study in cats, please visit the official clinical trials site at: http://research.vet.upenn.edu/CurrentClinicalTrials/DentistryOralSurgery/FelineOralSqumousCellCarcinoma/tabid/3459/Default.aspx
If you have a feline patient that may qualify for this study, please contact the University of Pennsylvania Veterinary Clinical Investigation Center for more information at: 215-573-0302 or via email at vcic@vet.upenn.edu.
